Market Watch
08 Sept 2026, 13:53 UTC · 2d ago
Novartis's failed trial for cholesterol drug leads to broad biopharma selloff
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst





